Appili Therapeutics Raises an Additional $4.3 Million in Oversubscribed Financing to Advance its Anti-infective Pipeline

World News: . []

Appili Therapeutics Inc the Company or “Appili”), a biopharmaceutical company developing and commercializing anti-infective drugs announced today it raised an additional 364339000 in an oversubscribed pr ivate p...

More news and information about Appili Therapeutics Inc.

Published By:

Business Wire: 12:17 GMT Wednesday 7th February 2018

Published: .

Search for other references to "appili" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
Privacy Policy | Terms and Conditions | Contact Us